$PRGO Cashflow Statement | Understand Stock

$PRGO

$16.02 +$0.20 (1.26%) Close

$PRGO Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash Flows From (For) Operating Activities
Net income (loss)
Adjustments to derive cash flows:
Depreciation and amortization
Impairment charges
Share-based compensation
Restructuring charges
Settlement of interest rate derivatives
Amortization of debt discount
Gain (loss) on sale of business
Foreign currency remeasurement loss
Loss on extinguishment of debt
Gain on sale of assets
Dedesignation of interest rate swap agreements
Amortization on hedging instruments
Deferred income taxes
Other non-cash adjustments, net
Subtotal
(Decrease) increase in cash due to:
Accounts receivable
Inventories
Prepaid expenses and other current assets
Accounts payable
Payroll and related taxes
Accrued customer programs
Other accrued liabilities
Accrued income taxes
Other long term liabilities
Other operating, net
Subtotal
Net cash from operating activities
Cash Flows From (For) Investing Activities
Proceeds from royalty rights
Acquisitions of businesses, net of cash acquired
Purchase of equity method investment
Proceeds from the Royalty Pharma contingent milestone
Asset (acquisitions) sales, net
Asset acquisitions, net
Settlement of foreign currency derivatives
Proceeds from sale of assets
Additions to property, plant and equipment
Net proceeds from sale of businesses
Other investing, net
Net cash (for) from investing activities

Cash Flows From (For) Financing Activities
Borrowings (repayments) of revolving credit agreements and other financing, net
Issuances of long-term debt
Payments on long-term debt
Issuance of ordinary shares
Premiums on early debt retirement
Payments for debt issuance costs
Repurchase of ordinary shares
Cash dividends
Shares used to settle taxes
Other financing, net
Net cash for financing activities

Effect of exchange rate changes on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents of continuing operations, beginning of period
Cash and cash equivalents
Cash and cash equivalents held for sale, beginning of period
Cash and cash equivalents of continuing operations, end of period
Supplemental Disclosures of Cash Flow Information
Cash paid/received during the year for:
Interest paid
Interest received
Income taxes paid
Income taxes refunded

Comments